Seaspine Holdings Quick Ratio (SPNE) starting from the third quarter 2022 to third quarter 2021, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Seaspine Holdings Corporation  (NASDAQ: SPNE)

Seaspine Holdings's Quick Ratio

SPNE's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2022, Quick Ratio fell to 0.85 below Seaspine Holdings Corporation average.

Within Medical Equipment & Supplies industry 162 other companies have achieved higher Quick Ratio than Seaspine Holdings in third quarter 2022. While Quick Ratio total ranking in the third quarter 2022 has deteriorated compared to the prior quarter from 2207 to 2693.

Explain Quick Ratio?
How much Cash & cash equivalents SPNE´s has?
What are SPNE´s Current Liabilities?




SPNE Quick Ratio (Sep 30 2022)
Q3
(Jun 30 2022)
Q2
(Mar 31 2022)
Q1
(Dec 31 2021)
Q4
(Sep 30 2021)
Q3
Y / Y Current Liabilities Change 15.41 % 24.94 % 82.71 % 72.42 % 32.94 %
Y / Y Cash & cash equivalent Change -54.35 % -45.25 % -7.2 % 8.19 % 9.87 %
Quick Ratio MRQ 0.85 1.21 1.12 1.57 2.15
SPNE's Total Ranking # 2693 # 2207 # 2292 # 1945 # 1703
Seq. Current Liabilities Change 1.11 % -25.37 % 37.69 % 11.08 % 9.45 %
Seq. Cash & cash equivalent Change -29.23 % -18.86 % -2.01 % -18.87 % -15.13 %



Quick Ratio third quarter 2022 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 163
Healthcare Sector # 951
Overall Market # 2693


Quick Ratio Statistics
High Average Low
3.53 1.3 0.02
(Mar 31 2020)   (Dec 31 2014)




Financial Statements
Seaspine Holdings's Current Liabilities $ 55 Millions Visit SPNE's Balance sheet
Seaspine Holdings's Cash & cash equivalent $ 47 Millions Visit SPNE's Balance sheet
Source of SPNE's Sales Visit SPNE's Sales by Geography


Cumulative Seaspine Holdings's Quick Ratio

SPNE's Quick Ratio for the trailling 12 Months

SPNE Quick Ratio

(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
(Mar 31 2022)
12 Months
(Dec 31 2021)
12 Months
(Sep 30 2021)
12 Months
Y / Y Current Liabilities TTM Growth 45.39 % 51.94 % 49.94 % 36.72 % 20.42 %
Y / Y Cash & cash equivalent TTM Growth -28.45 % -12.01 % 8.21 % 4.86 % 21.5 %
Quick Ratio TTM 1.18 1.46 1.78 2.14 2.39
Total Ranking TTM # 4576 # 4528 # 4507 # 950 # 1111
Seq. Current Liabilities TTM Growth 3.22 % 5 % 17.93 % 13.74 % 7.87 %
Seq. Cash & cash equivalent TTM Growth -16.72 % -14.09 % -1.6 % 1.62 % 2.43 %


On the trailing twelve months basis Due to rise in Current Liabilities in the Q3 2022 to $55.05 millions, cumulative Quick Ratio decreased to 1.18 below the Seaspine Holdings Corporation average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 245 other companies have achieved higher Quick Ratio than Seaspine Holdings. While Quick Ratio total ranking has deteriorated compared to the previous twelve months ending in the second quarter 2022 from 4528 to 4576.

Explain Quick Ratio?
How much Cash & cash equivalents SPNE´s has?
What are SPNE´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 246
Healthcare Sector # 1182
Within the Market # 4576


trailing twelve months Quick Ratio Statistics
High Average Low
2.79 1.42 0.5
(Dec 31 2020)   (Sep 30 2018)




Companies with similar Quick Ratio in the quarter ending Sep 30 2022, within Medical Equipment & Supplies Industry Quick RatioSep 30 2022 MRQ Cash & cash equivalentSep 30 2022 MRQ Current Liabilities
Alphatec Holdings Inc   2.26 $ 106.112  Millions$ 46.924  Millions
Sharecare Inc   2.25 $ 202.564  Millions$ 89.944  Millions
Cytosorbents Corporation  2.23 $ 22.552  Millions$ 10.119  Millions
Atricure Inc   2.13 $ 122.644  Millions$ 57.598  Millions
Harvard Apparatus Regenerative Technology Inc   2.06 $ 2.971  Millions$ 1.442  Millions
Establishment Labs Holdings Inc   2.02 $ 65.349  Millions$ 32.376  Millions
Stereotaxis Inc   1.99 $ 30.938  Millions$ 15.554  Millions
Lensar Inc   1.97 $ 19.293  Millions$ 9.788  Millions
Petvivo Holdings Inc   1.97 $ 2.350  Millions$ 1.194  Millions
Edwards Lifesciences Corporation  1.89 $ 1,738.700  Millions$ 917.900  Millions
T2 Biosystems Inc   1.89 $ 20.366  Millions$ 10.780  Millions
Globus Medical Inc   1.87 $ 271.063  Millions$ 145.255  Millions
Myomo Inc   1.80 $ 7.420  Millions$ 4.114  Millions
Warby Parker Inc   1.78 $ 197.885  Millions$ 111.484  Millions
Livanova Plc  1.76 $ 506.279  Millions$ 288.016  Millions
Pear Therapeutics Inc   1.74 $ 83.619  Millions$ 48.155  Millions
Iridex Corp  1.73 $ 15.856  Millions$ 9.157  Millions
Abiomed Inc   1.69 $ 182.335  Millions$ 108.098  Millions
Icad Inc  1.68 $ 24.590  Millions$ 14.601  Millions
Integra Lifesciences Holdings Corp  1.68 $ 511.937  Millions$ 304.452  Millions
Sintx Technologies Inc   1.66 $ 4.779  Millions$ 2.872  Millions
Polypid Ltd  1.66 $ 12.594  Millions$ 7.594  Millions
Mimedx Group Inc   1.60 $ 73.217  Millions$ 45.858  Millions
West Pharmaceutical Services Inc   1.60 $ 729.000  Millions$ 456.700  Millions
Vapotherm Inc   1.58 $ 28.709  Millions$ 18.214  Millions
Si bone inc   1.53 $ 26.299  Millions$ 17.227  Millions
Jin Medical International Ltd  1.52 $ 2.276  Millions$ 1.494  Millions
Biolife Solutions Inc   1.51 $ 61.619  Millions$ 40.758  Millions
Innovage Holding Corp   1.43 $ 188.222  Millions$ 131.415  Millions
Agape Atp Corporation  1.43 $ 1.585  Millions$ 1.107  Millions

Date modified: 2026-08-29T17:30:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.